Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baek, K. | - |
dc.contributor.author | Park, H.-J. | - |
dc.contributor.author | Baek, J.-H. | - |
dc.contributor.author | Kim, Hyung Ryong | - |
dc.date.available | 2017-12-11T00:54:30Z | - |
dc.date.created | 2017-12-07 | - |
dc.date.issued | 2017-10 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11750/4750 | - |
dc.description.abstract | Sympathetic nervous system stimulation-induced β-adrenergic signal transduction is known to induce bone loss and increase of osteoclast activity. Although isoproterenol, a nonspecific β-adrenergic receptor agonist, has been shown to increase receptor activator of NF-κB ligand (RANKL), the details of the regulatory mechanisms remain unclear. In the present study, we investigated the role of the nuclear factor of activated T-cells (NFAT) in isoproterenol-induced RANKL expression in C2C12 and in primary cultured mouse calvarial cells. Isoproterenol increased nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) and RANKL expressions at both mRNA and protein levels and increased NFAT reporter activity. NFATc1 knockdown blocked isoproterenolmediated RANKL expression. Isoproterenol also promoted cAMP response element-binding protein 1 (CREB1) and activating transcription factor 4 (ATF4) phosphorylation. Isoproterenolmediated transcriptional activation of NFAT was blocked by protein kinase A (PKA) inhibitor H89. Isoproterenol-induced CREB1, ATF4, NFATc1, and RANKL expressions were suppressed by H89. Mutations in cAMP response element-like or NFAT-binding element suppressed isoproterenolinduced RANKL promoter activity. Chromatin immunoprecipitation analysis demonstrated that isoproterenol increased NFAT-binding and ATF4-binding activities on the mouse RANKL promoter, but did not increase CREB1-binding activity. Association of NFATc1 and ATF4 was not observed in a co-immunoprecipitation study. ATF4 knockdown suppressed isoproterenol-induced NFAT binding to the RANKL promoter, whereas NFATc1 knockdown did not suppress isoproterenol-induced ATF4 binding to the RANKL promoter. ATF4 knockdown suppressed isoproterenol-induced expressions of NFATc1 and RANKL. These results suggest that isoproterenol increases RANKL expression in an ATF4/NFATc1-dependent manner. © 2017 by the author. Licensee MDPI, Basel, Switzerland. | - |
dc.language | English | - |
dc.publisher | Multidisciplinary Digital Publishing Institute (MDPI) | - |
dc.title | Isoproterenol increases RANKL expression in a ATF4/NFATc1-dependent manner in mouse osteoblastic cells | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/ijms18102204 | - |
dc.identifier.scopusid | 2-s2.0-85032011668 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, v.18, no.10 | - |
dc.description.isOpenAccess | TRUE | - |
dc.subject.keywordAuthor | Activating transcription factor 4 (ATF4) | - |
dc.subject.keywordAuthor | Isoproterenol | - |
dc.subject.keywordAuthor | Nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) | - |
dc.subject.keywordAuthor | RANKL transcription | - |
dc.subject.keywordAuthor | β-adrenergic receptor | - |
dc.subject.keywordPlus | KAPPA-B LIGAND | - |
dc.subject.keywordPlus | SYMPATHETIC-NERVOUS-SYSTEM | - |
dc.subject.keywordPlus | HIGH EXTRACELLULAR CALCIUM | - |
dc.subject.keywordPlus | RECEPTOR ACTIVATOR | - |
dc.subject.keywordPlus | BONE LOSS | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | PROPRANOLOL | - |
dc.subject.keywordPlus | RATS | - |
dc.subject.keywordPlus | DIFFERENTIATION | - |
dc.subject.keywordPlus | OVARIECTOMY | - |
dc.citation.number | 10 | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.volume | 18 | - |